MUMBAI: Israel’s Zebra-Med and Apollo Hospitals have announced the launch of their strategic collaboration that will focus on validating and deploying AI based tools at scale across India.
As part of the tie-up, the companies shall jointly receive support from India-Israel Industrial R&D and Technological Innovation Fund (I4F) for their US$ 4.9 million project to co-develop and provide clinical validation, and evidence of the efficacy of, radiology Al based tools in India as per I4F norms, a release from Apollo Hospitals said.
On the partnership, Apollo Hospitals joint managing director, Ms Sangita Reddy, said, “Apollo’s clinical and scientific depth and Zebra-Med’s expertise in AI complement each other perfectly. This project is part of our continuing endeavor to design new tools to improve healthcare access and deliver best outcomes to patients at lower cost.”
“The arsenal of algorithms will include deep learning algorithms for the detection of acute conditions such as brain bleeds in head CTs and Pneumothorax in chest X-ray, detection of breast cancer in mammograms, Osteoporosis in CT scans and 40 other conditions,” she said.
The final developed project will be able to assist as a primary screening method for major diseases such as TB in large scale screenings. Both companies will focus on development of AI-based chest X-ray interpretation tool for TB.
The project will also modify existing algorithms to make them suitable for the Indian population. The final product will assist in providing high quality radiology access to remote locations by alerting the presence of critical findings immediately. This will help provide timely, cost-effective, quality care to patients in remote and rural locations.